About the position
Kalpana Laboratory | Department of Genetics | Albert Einstein College of Medicine | New York
The Kalpana laboratory invites applications for an NIH-funded postdoctoral position available immediately. We seek a motivated, curious scientist to lead projects at the intersection of Virology, structural biology, molecular virology, and therapeutic discovery.
Research opportunities: Our laboratory investigates interactions among HIV-1 integrase, the host protein INI1/SMARCB1, and RNA, with the goal of identifying new approaches to inhibit viral replication. Our discovery that the integrase-binding domain of INI1/SMARCB1 mimics RNA (Nature Communications) has informed the identification of a novel class of compounds that inhibit integrase–RNA interactions and HIV-1 replication.
The successful candidate will have opportunities to:
-
Define mechanisms of antiviral action through molecular, structural, biochemical, and virological studies of compounds targeting integrase–INI1 and -RNA interactions.
-
Uncover how host–virus interactions regulate HIV-1 replication, focusing on integrase and INI1/SMARCB1.
-
Investigate HIV-1 persistence using single-molecule RNA fluorescence in situ hybridization (smRNA-FISH) to inform HIV cure strategies (related publication).
Scientific environment: The postdoctoral fellow will spearhead mechanistic studies, expand their expertise across complementary disciplines, and collaborate with scientists and physicians at Albert Einstein College of Medicine and other institutions.
Mentoring and career development: The fellow will receive individualized mentoring from Dr. Kalpana to develop scientific independence and advance their career goals. Opportunities will include leading research projects, preparing manuscripts, presenting at conferences, and building interdisciplinary collaborations.
PI288404811
Tagged as: Life Sciences
This listing was collected from a public source and is reproduced here for
information only. Always confirm the details on the original posting before applying.
View the original posting